Report Debunks Conservative Case for Sex-Selection Abortion Bans
By Jessica Mason Pieklo,
RH Reality Check
| 06. 04. 2014
Untitled Document
This week, the International Human Rights Clinic at the University of Chicago Law School, the National Asian Pacific American Women’s Forum, and Advancing New Standards in Reproductive Health at the University of California, San Francisco, released an important new report that corrects the significant misinformation lawmakers rely on to introduce and pass sex-selection abortion bans around the country.
Over the past five years, more than 60 sex-selection abortion bills have been introduced both at state and federal levels. These bans, often proposed in the context of race or with legislation that includes race-selection bans as well, are steeped in stereotypes that are designed to provide an entry-point into banning abortions entirely. In South Dakota, for example, lawmakers proposed the state’ssex-selection abortion ban in response to changing demographics, claiming an increase in Asian immigrants would fuel an increase in acceptance of sex-selective abortions. Meanwhile, in Arizona, lawmakers attempted to use harmful racial stereotypes against Black women to justify its ban, citing higher rates of abortion among Black women as evidence that women of color were being coerced into having more abortions than other women as part of some racist plot...
Related Articles
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...
By Jason Kehe, Wired | 04.11.2024
God help the babies! Or, absent God, a fertility startup called Orchid. It offers prospective parents a fantastical choice: Have a regular baby or have an Orchid baby. A regular baby might grow up and get cancer. Or be born...
By Nick Paul Taylor, BioSpace | 03.14.2024
A U.K. watchdog balked at the cost-effectiveness of Vertex Pharmaceuticals’ CRISPR-based sickle cell disease therapy Thursday, recommending against funding the treatment unless uncertainties can be cleared up satisfactorily.
The U.K. became the first country to authorize Vertex’s Casgevy (exagamglogene...